Gene expression analysis of induced pluripotent stem cells from aneuploid chromosomal syndromes

BMC Genomics

Volumn 14, Issue , 2013, Pages

  Zhang, Ruosi ^a,b   Hao, Lili ^a   Wang, Lingping ^a,b   Chen, Meili ^a,b   Li, Wen ^c   Li, Rujiao ^a   Yu, Jun ^a   Xiao, Jingfa ^a   Wu, Jiayan ^a  

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; MONOSOMY X; NEXT GENERATION SEQUENCING; PHENOTYPE; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; TRISOMY 13; TRISOMY 8; TURNER SYNDROME; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; CHROMOSOME DISORDER; DNA SEQUENCE; GENETICS; HUMAN CHROMOSOME; METABOLISM; PLURIPOTENT STEM CELL; PROCEDURES;

ANEUPLOIDY; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN; GENE EXPRESSION PROFILING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; SEQUENCE ANALYSIS, DNA;

EID: 84920869718     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-S5-S8     Document Type: Article

References (62)

1. Lejeune J, Turpin R, Gautier M: [Mongolism; a chromosomal disease (trisomy)]. Bulletin de l'Academie nationale de medecine 1959, 143(11-12):256-265
2. Hassold T, Hunt P: To err (meiotically) is human: the genesis of human aneuploidy. Nature reviews Genetics 2001, 2(4):280-291
3. Simpson JL: Causes of fetal wastage. Clinical obstetrics and gynecology 2007, 50(1):10-30
4. Mao R, Zielke CL, Zielke HR, Pevsner J: Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 2003, 81(5):457-467
5. Saran NG, Pletcher MT, Natale JE, Cheng Y, Reeves RH: Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Human molecular genetics 2003, 12(16):2013-2019
6. Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, et al: Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome research 2004, 14(7):1258-1267
7. Lyle R, Gehrig C, Neergaard-Henrichsen C, Deutsch S, Antonarakis SE: Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. Genome research 2004, 14(7):1268-1274
8. Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H, Kim JW, Ruczinski I, Downey TJ, Pevsner J: Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome biology 2005, 6(13):R107
9. Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S: Gene expression profiling in the adult Down syndrome brain. Genomics 2007, 90(6):647-660
10. Chou CY, Liu LY, Chen CY, Tsai CH, Hwa HL, Chang LY, Lin YS, Hsieh FJ: Gene expression variation increase in trisomy 21 tissues. Mammalian genome: official journal of the International Mammalian Genome Society 2008, 19(6):398-405
11. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW: Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(23):9425-9429
12. Lavon N, Narwani K, Golan-Lev T, Buehler N, Hill D, Benvenisty N: Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells 2008, 26(7):1874-1882
13. Biancotti JC, Narwani K, Buehler N, Mandefro B, Golan-Lev T, Yanuka O, Clark A, Hill D, Benvenisty N, Lavon N: Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells 2010, 28(9):1530-1540
14. Narwani K, Biancotti JC, Golan-Lev T, Buehler N, Hill D, Shifman S, Benvenisty N, Lavon N: Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In vitro cellular & developmental biology Animal 2010, 46(3-4):309-316
15. Biancotti JC, Narwani K, Mandefro B, Golan-Lev T, Buehler N, Hill D, Svendsen CN, Benvenisty N: The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem cell research 2012, 9(3):218-224
16. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872
17. Li W, Wang X, Fan W, Zhao P, Chan YC, Chen S, Zhang S, Guo X, Zhang Y, Li Y, et al: Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Human molecular genetics 2012, 21(1):32-45
18. Shi Y, Kirwan P, Smith J, MacLean G, Orkin SH, Livesey FJ: A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Science translational medicine 2012, 4(124):124ra129
19. FitzPatrick DR, Ramsay J, McGill NI, Shade M, Carothers AD, Hastie ND: Transcriptome analysis of human autosomal trisomy. Human molecular genetics 2002, 11(26):3249-3256
20. Nawata H, Kashino G, Tano K, Daino K, Shimada Y, Kugoh H, Oshimura M, Watanabe M: Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PloS one 2011, 6(9):e25319
21. Bahn S, Mimmack M, Ryan M, Caldwell MA, Jauniaux E, Starkey M, Svendsen CN, Emson P: Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 2002, 359(9303):310-315
22. Epstein CJ: The consequences of chromosome imbalance. American journal of medical genetics Supplement 1990, 7:31-37
23. FitzPatrick DR: Transcriptional consequences of autosomal trisomy: primary gene dosage with complex downstream effects. Trends in genetics: TIG 2005, 21(5):249-253
24. Costa V, Angelini C, D'Apice L, Mutarelli M, Casamassimi A, Sommese L, Gallo MA, Aprile M, Esposito R, Leone L, et al: Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PloS one 2011, 6(4):e18493
25. Xiong Y, Chen X, Chen Z, Wang X, Shi S, Zhang J, He X: RNA sequencing shows no dosage compensation of the active X-chromosome. Nature genetics 2010, 42(12):1043-1047
26. Marguerat S, Bahler J: RNA-seq: from technology to biology. Cellular and molecular life sciences: CMLS 2010, 67(4):569-579
27. Allison DB, Cui X, Page GP, Sabripour M: Microarray data analysis: from disarray to consolidation and consensus. Nature reviews Genetics 2006, 7(1):55-65
28. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y: RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome research 2008, 18(9):1509-1517
29. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome biology 2003, 4(5):P3
30. Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, Difilippantonio MJ, Ried T: Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer research 2004, 64(19):6941-6949
31. Bixby JL, Harris WA: Molecular mechanisms of axon growth and guidance. Annual review of cell biology 1991, 7:117-159
32. Dickinson RE, Duncan WC: The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction 2010, 139(4):697-704
33. Andrews W, Liapi A, Plachez C, Camurri L, Zhang J, Mori S, Murakami F, Parnavelas JG, Sundaresan V, Richards LJ: Robo1 regulates the development of major axon tracts and interneuron migration in the forebrain. Development 2006, 133(11):2243-2252
34. Ren T, Anderson A, Shen WB, Huang H, Plachez C, Zhang J, Mori S, Kinsman SL, Richards LJ: Imaging, anatomical, and molecular analysis of callosal formation in the developing human fetal brain. The anatomical record Part A, Discoveries in molecular, cellular, and evolutionary biology 2006, 288(2):191-204
35. Robinow M, Haney N, Chen H, Sorauf T, Van Dyke DL, Babu VR, Powell S, Maliszewski W, Guerin S, Landers JW: Secondary trisomy or mosaic 'tetrasomy' 8p. American journal of medical genetics 1989, 32(3):320-324
36. Markov D, Ivanov S, Popivanova P: [Warkany syndrome associated with agenesis of the corpus callosum]. Akusherstvo i ginekologiia 2007, 46(2):48-50
37. Carter MT, St Pierre SA, Zackai EH, Emanuel BS, Boycott KM: Phenotypic delineation of Emanuel syndrome (supernumerary derivative 22 syndrome): Clinical features of 63 individuals. American journal of medical genetics Part A 2009, 149A(8):1712-1721
38. Klein R: Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nature neuroscience 2009, 12(1):15-20
39. Balci S, Gucer S, Orhan D, Karagoz T: A well-documented trisomy 13 case presenting with a number of common and uncommon features of the syndrome. The Turkish journal of pediatrics 2008, 50(6):595-599
40. Chacon MR, Fazzari P: FAK: dynamic integration of guidance signals at the growth cone. Cell adhesion & migration 2011, 5(1):52-55
41. Niclou SP, Jia L, Raper JA: Slit2 is a repellent for retinal ganglion cell axons. The Journal of neuroscience: the official journal of the Society for Neuroscience 2000, 20(13):4962-4974
42. Feldheim DA, Kim YI, Bergemann AD, Frisen J, Barbacid M, Flanagan JG: Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron 2000, 25(3):563-574
43. Woo S, Rowan DJ, Gomez TM: Retinotopic mapping requires focal adhesion kinase-mediated regulation of growth cone adhesion. The Journal of neuroscience: the official journal of the Society for Neuroscience 2009, 29(44):13981-13991
44. Lorke DE, Winking H: Histogenesis of the retina in murine trisomy 19. Brain research bulletin 1986, 16(6):845-851
45. Chan A, Lakshminrusimha S, Heffner R, Gonzalez-Fernandez F: Histogenesis of retinal dysplasia in trisomy 13. Diagnostic pathology 2007, 2:48
46. Guan CB, Xu HT, Jin M, Yuan XB, Poo MM: Long-range Ca2+ signaling from growth cone to soma mediates reversal of neuronal migration induced by slit-2. Cell 2007, 129(2):385-395
47. Henley J, Poo MM: Guiding neuronal growth cones using Ca2+ signals. Trends in cell biology 2004, 14(6):320-330
48. Moreland RS, Cilea J, Moreland S: Calcium dependent regulation of vascular smooth muscle contraction. Advances in experimental medicine and biology 1991, 308:81-94
49. O'Gorman CS, Syme C, Lang J, Bradley TJ, Wells GD, Hamilton JK: An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome. Clinical endocrinology 2013, 78(6):907-913
50. Michael SK, Surks HK, Wang Y, Zhu Y, Blanton R, Jamnongjit M, Aronovitz M, Baur W, Ohtani K, Wilkerson MK, et al: High blood pressure arising from a defect in vascular function. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(18):6702-6707
51. Hermes M, Eichhoff G, Garaschuk O: Intracellular calcium signalling in Alzheimer's disease. Journal of cellular and molecular medicine 2010, 14(1-2):30-41
52. Boveri T: über mehrpolige Mitosen als Mittel zur analyse des zellkerns. Verh d physmed Ges Würzburg N F 1902, 35:67-90
53. Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R: How aneuploidy may cause cancer and genetic instability. Anticancer research 1999, 19(6A):4887-4906
54. Schoch C, Kohlmann A, Dugas M, Kern W, Schnittger S, Haferlach T: Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups. Genes, chromosomes & cancer 2006, 45(12):1164-1168
55. Mertens F, Sallerfors B, Heim S, Johansson B, Kristoffersson U, Malm C, Mitelman F: Trisomy 13 as a primary chromosome aberration in acute leukemia. Cancer genetics and cytogenetics 1991, 56(1):39-44
56. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R: Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(3):1124-1129
57. Hasle H, Olsen JH, Nielsen J, Hansen J, Friedrich U, Tommerup N: Occurrence of cancer in women with Turner syndrome. British journal of cancer 1996, 73(9):1156-1159
58. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA: Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. The lancet oncology 2008, 9(3):239-246
59. Farooque A, Atapattu N, Amarasena S, Hogler W, English MW, Kirk JM: An association of craniopharyngioma in Turner syndrome. Pediatric blood & cancer 2013, 60(6):E7-9
60. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulkner GJ, Brown MK, Taylor DF, Steptoe AL, Wani S, Bethel G, et al: Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nature methods 2008, 5(7):613-619
61. Lu X, Shapiro JA, Ting CT, Li Y, Li C, Xu J, Huang H, Cheng YJ, Greenberg AJ, Li SH, et al: Genome-wide misexpression of X-linked versus autosomal genes associated with hybrid male sterility. Genome research 2010, 20(8):1097-1102
62. Wang L, Feng Z, Wang X, Zhang X: DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 2010, 26(1):136-138